Founded in 2018, Sprout Bioventures invests in startups researching compelling targets in human biology derived from population-wide genetic association studies. The firm has invested in fourteen companies in the fields of biotechnology, drug discovery, and drug delivery. Sprout Bioventures typically invests in rounds with three participants and is often co-financed by BioAdvance, Viva Biotech, Viva BioInnovator, and Lumira Ventures. The firm prefers to invest in healthcare sectors and targets startups that are 4-5 years old.